• Mashup Score: 4
    Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality - 4 year(s) ago

    Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and proven treatments are limited. Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 is among many approaches being studied as potentially efficacious therapy. We are conducting a prospective, propensity score-matched study assessing the…

    Source: The American Journal of Pathology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Aiims1742
      Aiims1742

      Smaller peer reviewed study from @MethodistHosp in 316 patients shows comparable findings of #COVID19 convalescent plasma on outcomes - determinants include starting Rx within 3D of diagnosis & higher antibody titers in product. https://t.co/ZrYK7M0RhE

  • Mashup Score: 0
    Return of Individual Research Results - 4 year(s) ago

    The recent movement toward returning individual research results to study subjects/participants generates ethical and legal challenges for laboratories performing research on human biospecimens. The concept of an individual’s interest in knowing the results of testing on their tissue is pitted against individual and systemic risks and an established legal framework regulating the performance of…

    Source: The American Journal of Pathology
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ELS_Cardiology
      ELS_Cardiology

      From The American Journal of Pathology: Return of Individual Research Results A Guide for Biomedical Researchers Utilizing Human Biospecimens @ASIPath @AJPathology https://t.co/DmCs9tqLQr